Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer

 Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer

Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer

Shots:

  • Roche has acquired Stratos Genomics to facilitate the development of its nanopore sequencer to provide the healthcare community and ultimately patients with faster and cheaper clinical diagnostic testing
  • The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). The addition of the SBX chemistry is expected to provide the HCPs an affordable, fast and flexible result, for multiple targeted clinical applications along with whole-exome and whole-genome sequencing
  • Stratos Genomics will continue its operations in Seattle, Washington, US. Gene sequencing technology plays a critical role in personalized healthcare and clinical diagnostics of the future

Click here ­to­ read full press release/ article | Ref: Roche | Image: Stratos Genomics

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post